At the Fortune Brainstorm Tech Dinner in Las Vegas, Fortune's Andrew Nusca interviews Mark Cuban about his work with Cost Plus Drugs. Cuban discusses disrupting the pharmaceutical industry, tackling ...

"There's nobody who looks at the healthcare system or the pharmaceutical industry and says ‘wow, that’s well run.'" ...

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...

More than 110,000 North Carolinians are projected to benefit from a $2,000 annual cap on out-of-pocket costs for covered prescription drugs for Medicare Part D participants.

Medicare Advantage continues to become increasingly popular among millions of Americans across the United States, but how do ...

Cost Plus Drugs aims to drive down the price of medicines broadly by selling them at a set 15% markup over their cost, plus ...

Amgen is on pace to return to its pre-Horizon capital structure by the end of 2025. Learn why I upgrade AMGN stock from hold ...

The year 2024 was arguably the last time in the current Marcos administration that seeking constitutional revision was ...

If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs would be available at cost plus 15%, and the amount of money spent on drugs would decline ...

The preventable fentanyl-poisoning death of University of Victoria student last January shocked B.C., and led to a long list ...